News Image

Uncovering Dividend Opportunities with NYSE:BMY.

By Mill Chart

Last update: Jan 25, 2024

Discover BRISTOL-MYERS SQUIBB CO (NYSE:BMY)—a stock that our stock screener has recognized as a solid dividend pick with strong fundamentals. NYSE:BMY showcases decent financial health and profitability while providing a sustainable dividend. We'll explore the specifics further.

Understanding NYSE:BMY's Dividend

ChartMill assigns a Dividend Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing various dividend elements, such as yield, historical performance, dividend growth, and sustainability. NYSE:BMY has been awarded a 7 for its dividend quality:

  • With a Yearly Dividend Yield of 4.79%, BMY is a good candidate for dividend investing.
  • BMY's Dividend Yield is rather good when compared to the industry average which is at 4.42. BMY pays more dividend than 97.04% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 2.50, BMY pays a better dividend.
  • The dividend of BMY is nicely growing with an annual growth rate of 6.94%!
  • BMY has been paying a dividend for at least 10 years, so it has a reliable track record.

Exploring NYSE:BMY's Health

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:BMY has earned a 5 out of 10:

  • The Altman-Z score of BMY (2.36) is better than 72.41% of its industry peers.
  • The Debt to FCF ratio of BMY is 3.22, which is a good value as it means it would take BMY, 3.22 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 3.22, BMY belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.

Profitability Examination for NYSE:BMY

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:BMY, the assigned 8 is a significant indicator of profitability:

  • BMY has a better Return On Assets (9.08%) than 93.10% of its industry peers.
  • Looking at the Return On Equity, with a value of 28.57%, BMY belongs to the top of the industry, outperforming 94.58% of the companies in the same industry.
  • The Return On Invested Capital of BMY (13.32%) is better than 91.13% of its industry peers.
  • The 3 year average ROIC (9.56%) for BMY is below the current ROIC(13.32%), indicating increased profibility in the last year.
  • The Profit Margin of BMY (18.44%) is better than 93.60% of its industry peers.
  • In the last couple of years the Profit Margin of BMY has grown nicely.
  • The Operating Margin of BMY (24.00%) is better than 92.12% of its industry peers.
  • The Gross Margin of BMY (76.70%) is better than 82.76% of its industry peers.
  • In the last couple of years the Gross Margin of BMY has grown nicely.

More Best Dividend stocks can be found in our Best Dividend screener.

Our latest full fundamental report of BMY contains the most current fundamental analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (4/19/2024, 7:04:00 PM)

After market: 48.93 0 (0%)

48.93

+0.63 (+1.3%)

BMY News

News Image2 days ago - Yahoo Finance3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations

These stocks pay between 3.2% and 6.7% in dividends.

News Image2 days ago - The Motley Fool3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations

These stocks pay between 3.2% and 6.7% in dividends.

News Image2 days ago - InvestorPlaceThese 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

News Image3 days ago - The Motley FoolGot $500? 3 Healthcare Stocks to Buy and Hold Forever

Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.

News Image3 days ago - Yahoo FinanceGot $500? 3 Healthcare Stocks to Buy and Hold Forever

Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.

News Image4 days ago - AB NewswireNavigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
News Image4 days ago - InvestorPlace3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

News Image5 days ago - The Motley Fool2 High-Yield Dividend Stocks to Buy and Hold for 10 Years

These income stocks look like good options at current levels.

News Image6 days ago - InvestorPlace3 Pharma Stocks That Are Money-Printing Machines in 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

News Image6 days ago - BusinessInsider3 Pharma Stocks That Are Money-Printing Machines in 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The future of the U.S. economy appears promising, with robust growth and strong...

News Image7 days ago - Investor's Business DailyNeumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.

News Image7 days ago - The Motley FoolBetter Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?

Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?

BMY Links
Follow us for more